The $1 Billion Equity Infrastructure: What the Gates Foundation's AI Health Commitment Means for Global HealthTech Markets
Dr. Dereck Mush, MD, MBA
Anthropic
Frontier AI company expanding Claude into scientific research and life sciences workflows.
What they do
Anthropic develops Claude and Claude Science for research workflows spanning literature analysis, bioinformatics, computational biology and auditable scientific work. In April 2026 it acquired Coefficient Bio in a reported stock transaction worth about $400 million.
The record
- Vertical
- Pharma & Drug Discovery
- Sub-segment
- Frontier AI
- Product type
- Platform software
- Stage
- Growth
- Headquarters
- San Francisco, CA, USA
- Region
- North America
- Founded
- 2021
- Total funding
- Undisclosed
Also in Pharma & Drug Discovery
Related on The Signal
Dr. Dereck Mush, MD, MBA
Closing the Assay Loop: Inside Anthropic's $400M Wet Lab Pivot
Dr. Dereck Mush, MD, MBA
What Pharma Is Buying From AI Drug Discovery: Inside AstraZeneca’s insitro Deal
Dr. Dereck Mush, MD, MBA
The Agentic Clinical AI Regulatory Frontier: What ADVOCATE's $62.7M Contract Actually Unlocks
Dr. Dereck Mush, MD, MBA